Volume 62, Issue 5, Pages (May 2015)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 64, Issue 3, Pages (March 2016)
Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic.
Volume 66, Issue 2, Pages (February 2017)
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Volume 66, Issue 5, Pages (May 2017)
Inflammasomes in liver diseases
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Volume 133, Issue 2, Pages (August 2007)
The inflammasome in liver disease
Volume 62, Issue 3, Pages (March 2015)
Obesity, inflammation, and liver cancer
Geoffrey W McCaughan, Amany Zekry  Journal of Hepatology 
Volume 136, Issue 1, Pages e2 (January 2009)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Nonalcoholic steatohepatitis
C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice  Belinda Knight, Janina E.E. Tirnitz–Parker,
Volume 57, Issue 5, Pages (November 2012)
Determinants of hepatic effector CD8+ T cell dynamics
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice  Bob Lubamba, François Huaux, Jean Lebacq, Etienne Marbaix,
Volume 64, Issue 1, Pages (January 2016)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 44, Issue 6, Pages (June 2006)
Volume 62, Issue 4, Pages (April 2015)
Volume 44, Issue 4, Pages (April 2006)
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 129, Issue 5, Pages (November 2005)
Volume 66, Issue 1, Pages (January 2017)
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 42, Issue 4, Pages (April 2005)
Volume 132, Issue 1, Pages (January 2007)
Volume 7, Issue 3, Pages (March 2008)
Volume 59, Issue 3, Pages (September 2013)
Volume 39, Issue 4, Pages (October 2003)
Volume 58, Issue 6, Pages (June 2013)
Volume 44, Issue 4, Pages (April 2006)
Corrigendum to “Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2”  Dewei Ye,
Volume 59, Issue 3, Pages (September 2013)
Volume 61, Issue 6, Pages (December 2014)
Volume 14, Issue 10, Pages (March 2016)
Volume 41, Issue 6, Pages (December 2004)
Volume 139, Issue 2, Pages e1 (August 2010)
Volume 60, Issue 4, Pages (April 2014)
Cannabinoid signaling and liver therapeutics
Volume 65, Issue 1, Pages (July 2016)
Volume 127, Issue 3, Pages (September 2004)
Volume 59, Issue 2, Pages (August 2013)
Volume 41, Issue 2, Pages (August 2004)
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Liver stem cells—prospects for clinical use
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 44, Issue 2, Pages (February 2006)
Volume 64, Issue 6, Pages (June 2016)
Volume 61, Issue 6, Pages (December 2014)
Volume 63, Issue 1, Pages (July 2015)
Macrophage heterogeneity in liver injury and fibrosis
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Volume 62, Issue 6, Pages (June 2015)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 71, Issue 1, Pages (July 2019)
The relationship between age and fat infiltration in liver and muscle
Volume 24, Issue 6, Pages (December 2016)
Platelets arrive at the scene of fibrosis……studies
Presentation transcript:

Volume 62, Issue 5, Pages 1180-1186 (May 2015) Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE∗3Leiden mice  Martine C. Morrison, Wen Liang, Petra Mulder, Lars Verschuren, Elsbet Pieterman, Karin Toet, Peter Heeringa, Peter Y. Wielinga, Teake Kooistra, Robert Kleemann  Journal of Hepatology  Volume 62, Issue 5, Pages 1180-1186 (May 2015) DOI: 10.1016/j.jhep.2014.12.011 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Mirtoselect attenuates hepatic steatosis in cholesterol-fed E3L mice. (A) Representative photomicrographs of liver sections of reference (REF), high-cholesterol control (HC) and Mirtoselect-treated mice (HCM). Mirtoselect attenuated HC diet-induced macrovesicular (B) and microvesicular (C) steatosis. (D) Hepatic steatosis in HC mice was mainly attributable to accumulation of cholesteryl esters, the build-up of which was decreased by Mirtoselect. (E) Hepatic triglycerides tended to accumulate in HC, which was not observed in HCM. (F) In HC-fed animals, some hypertrophic cells were CK18-deficient compared with neighbouring cells (arrows); presence of these cells was reduced in HCM. REF: non-cholesterol-fed reference, HC: high-cholesterol control, HCM: high-cholesterol+Mirtoselect. Data are mean±SD. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001 compared with HC. Journal of Hepatology 2015 62, 1180-1186DOI: (10.1016/j.jhep.2014.12.011) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Mirtoselect reduces hepatic inflammation in cholesterol-fed E3L mice. (A) Number of HC-induced inflammatory cell aggregates was reduced by Mirtoselect. HC diet induced Emr1 (B) and Ccl2 (C) gene expression was not affected by Mirtoselect. Mirtoselect reduced HC-induced Mpo gene expression (D) and number of MPO-positive cells as determined immunohistochemically (E). HC-induced gene expression of neutrophil chemoattractants Cxcl1 (F) and Cxcl2 (G) was less pronounced in HCM. REF: non-cholesterol-fed reference, HC: high-cholesterol control, HCM: high-cholesterol+Mirtoselect. Data are mean±SD. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001 compared with HC. Journal of Hepatology 2015 62, 1180-1186DOI: (10.1016/j.jhep.2014.12.011) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Development of hepatic fibrosis in cholesterol-fed E3L mice reduced by Mirtoselect. (A) Representative photomicrographs of picro-sirius red-stained liver sections show reduction of HC-induced collagen content in Mirtoselect-treated mice, which was confirmed by biochemical analysis of hepatic collagen content (B). (C) Induction of Col1a1 gene expression is prevented by Mirtoselect. Gene expression of hepatic stellate cell activation marker Acta2 (D) as well as pro-fibrotic cytokines Tgfb1 (E) and Tnf (F) was induced by HC, while this induction was less pronounced in HCM. REF: non-cholesterol-fed reference, HC: high-cholesterol control, HCM: high-cholesterol+Mirtoselect. Data are mean±SD. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001 compared with HC. Journal of Hepatology 2015 62, 1180-1186DOI: (10.1016/j.jhep.2014.12.011) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Mirtoselect reduces intrahepatic free cholesterol accumulation and crystallisation in cholesterol-fed E3L mice. (A) Intrahepatic free cholesterol levels correlated with hepatic inflammation (inflammatory aggregates per field) and (B) hepatic fibrosis (Col1a1 expression). (C) HC-induced hepatic free cholesterol accumulation was not observed in HCM. (D) Representative photomicrographs of liver cryosections (same field under bright-field and polarised-light microscopy) reveal presence of birefringent crystals in HC that were hardly observed in HCM. (E) Quantification of birefringent area shows strong HC-induced increase that is not observed in HCM. (F) Birefringent crystals stained prominently with free cholesterol staining filipin (same field under polarised-light and fluorescent microscopy). REF: non-cholesterol-fed reference, HC: high-cholesterol control, HCM: high-cholesterol+Mirtoselect. Data are mean±SD. ∗∗p<0.01 compared with HC. Journal of Hepatology 2015 62, 1180-1186DOI: (10.1016/j.jhep.2014.12.011) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions